| Serial Number | 85963028 |
| Word Mark | SMARTAG |
| Filing Date | Tuesday, June 18, 2013 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Thursday, October 5, 2023 |
| Registration Number | 5054933 |
| Registration Date | Tuesday, October 4, 2016 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 2, 2014 |
| Goods and Services | Pharmaceutical preparations for the prevention or treatment of human diseases, namely, diseases of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; chemical, biological and biochemical preparations for medical and pharmaceutical purposes, namely, antibody-drug conjugates or any protein conjugated to a drug, poly nucleotide, another protein, chemical, or other functional entity or such preparations used as linker or payload molecules therein used to treat cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; pharmaceutical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; biological preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; diagnostic preparations for medical purposes in connection with the diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; antibody preparations, namely, antibody or protein bioconjugates for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system, including antibody/protein-drug conjugates, antibody/protein-radiolabled conjugates and antibody/protein-imaging agent conjugates; chemical products for medical diagnostic use, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; biochemical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system |
| Pseudo Mark | SMAR TAG |
| Goods and Services | Chemical, biochemical and biological reagents in the nature of or used to create or improve antibody-drug conjugates or any protein conjugated to a drug, poly nucleotide, another protein, chemical, or other functional entity used in industry and science; chemicals for use in bioconjugation, reversible bioconjugation, irreversible bioconjugation, reversible cysteine protection, surface modification, and prodrug production for scientific use; biochemicals, namely, polypeptides, polypeptides for in vivo applications, polypeptides for in vitro applications, polynucleic acids, polynucleic acids for in vivo applications, and polynucleic acids for in vitro applications for scientific use; biomolecules, namely, proteins, peptides, antibodies, antibody fragments, antibody mimetic proteins, and polynucleic acids for scientific use; chemical products for diagnostic use, namely, conjugates of polypeptides with small molecule drugs, imaging agents, flourocromes and radiolabels for medical research applications; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in basic scientific research and development, medical research; diagnostic preparations for scientific or research use in connection with antibody drug conjugates; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 27, 2013 |
| Primary Code | 001 |
| First Use Anywhere Date | Monday, October 20, 2014 |
| First Use In Commerce Date | Monday, October 20, 2014 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 27, 2013 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, October 20, 2014 |
| First Use In Commerce Date | Monday, October 20, 2014 |
| Party Name | CATALENT PHARMA SOLUTIONS, INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Somerset, NJ 08873 |
| Party Name | CATALENT PHARMA SOLUTIONS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Somerset, NJ 08873 |
| Party Name | CATALENT PHARMA SOLUTIONS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Somerset, NJ 08873 |
| Event Date | Event Description |
| Thursday, June 27, 2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 21, 2013 | NEW APPLICATION ENTERED |
| Friday, June 28, 2013 | NOTICE OF PSEUDO MARK E-MAILED |
| Tuesday, September 10, 2013 | ASSIGNED TO EXAMINER |
| Monday, September 16, 2013 | NON-FINAL ACTION WRITTEN |
| Monday, September 16, 2013 | NON-FINAL ACTION E-MAILED |
| Monday, September 16, 2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 10, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 10, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 11, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 2, 2014 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 2, 2014 | NON-FINAL ACTION E-MAILED |
| Wednesday, April 2, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 17, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 17, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 17, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 9, 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 28, 2014 | ASSIGNED TO LIE |
| Tuesday, October 28, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, November 12, 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 2, 2014 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 2, 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, July 22, 2015 | ASSIGNED TO PETITION STAFF |
| Tuesday, December 23, 2014 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, June 16, 2015 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Thursday, July 16, 2015 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Saturday, July 25, 2015 | POST PUBLICATION AMENDMENT – NOT ENTERED |
| Tuesday, July 28, 2015 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 4, 2015 | TEAS PETITION TO DIRECTOR RECEIVED |
| Monday, August 31, 2015 | ASSIGNED TO PETITION STAFF |
| Wednesday, September 2, 2015 | PETITION TO DIRECTOR GRANTED |
| Friday, January 15, 2016 | SOU TEAS EXTENSION RECEIVED |
| Friday, January 15, 2016 | SOU EXTENSION 1 FILED |
| Friday, January 15, 2016 | SOU EXTENSION 1 GRANTED |
| Tuesday, January 19, 2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 13, 2016 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, July 13, 2016 | USE AMENDMENT FILED |
| Saturday, August 6, 2016 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, August 9, 2016 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, August 30, 2016 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, August 31, 2016 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, October 4, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, May 22, 2019 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Monday, October 4, 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, April 4, 2023 | TEAS SECTION 8 & 15 RECEIVED |
| Thursday, October 5, 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Saturday, October 4, 2025 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Wednesday, December 25, 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Thursday, October 5, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, October 5, 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |